AKRO

37.67

0.11% 0.04

시간 외 거래: 37.95 0.28 +0.74%

Akero Therapeutics Inc (AKRO)

개요 뉴스 가격 이력 옵션 체인 Financials AKRO 왜 하락? 토론 예측

전일 마감가:

$37.63

열려 있는:

$37.28

하루 거래량:

884.04K

Relative Volume:

0.65

시가총액:

$2.99B

수익:

순이익/손실:

$-237.22M

주가수익비율:

-9.9656

EPS:

-3.78

순현금흐름:

$-212.64M

1주 성능:

+0.19%

1개월 성능:

-16.70%

6개월 성능:

+21.91%

1년 성능:

+81.45%

1일 변동 폭

$37.28

$39.59

1주일 범위

$36.46

$39.59

52주 변동 폭

$17.86

$58.40

Akero Therapeutics Inc Stock (AKRO) Company Profile

명칭

Akero Therapeutics Inc

부문

Healthcare (1155)

산업

Biotechnology (677)

전화

650-487-6488

주소

601 GATEWAY BOULEVARD, SUITE 350, SOUTH SAN FRANCISCO, CA

직원

트위터

@akerotx

다음 수익 날짜

2024-11-11

최신 SEC 제출 서류

AKRO's Discussions on Twitter

AKRO을(를) 다른 주식과 비교

주식	가격	시가총액	매출	순이익	현금흐름	주당 순 이익
AKRO Akero Therapeutics Inc	37.67	2.99B	0	-237.22M	-212.64M	-3.78
VRTX Vertex Pharmaceuticals Inc	477.52	127.47B	11.02B	-535.60M	-978.00M	-2.20
REGN Regeneron Pharmaceuticals Inc	561.49	62.43B	14.20B	4.41B	3.54B	38.28
ARGX Argen X Se Adr	595.70	37.03B	2.19B	833.04M	-1.28B	12.71
ALNY Alnylam Pharmaceuticals Inc	232.75	31.06B	2.25B	-278.16M	-42.59M	-2.17
ONC Beigene Ltd Adr	229.22	26.16B	3.81B	-644.79M	-669.77M	-6.24

Akero Therapeutics Inc Stock (AKRO) Upgrades & Downgrades

날짜	액션	분석자	등급 변경
2025-01-30	업그레이드	BofA Securities	Neutral → Buy
2025-01-27	재확인	H.C. Wainwright	Buy
2024-11-18	개시	Citigroup	Buy
2024-04-22	재개	BofA Securities	Neutral
2023-09-19	개시	Cantor Fitzgerald	Overweight
2023-08-28	개시	UBS	Buy
2023-01-27	업그레이드	Morgan Stanley	Equal-Weight → Overweight
2022-09-14	업그레이드	Evercore ISI	In-line → Outperform
2021-10-19	다운그레이드	Morgan Stanley	Overweight → Equal-Weight
2021-09-10	개시	BofA Securities	Buy
2021-02-26	개시	Guggenheim	Buy
2020-09-10	개시	Morgan Stanley	Overweight
2020-07-20	재확인	H.C. Wainwright	Buy
2020-07-07	개시	Chardan Capital Markets	Buy
2020-07-01	재확인	H.C. Wainwright	Buy
2020-03-02	개시	H.C. Wainwright	Buy
2020-02-10	개시	Canaccord Genuity	Buy
2019-07-15	개시	Evercore ISI	Outperform
2019-07-15	개시	JP Morgan	Overweight
2019-07-15	개시	Jefferies	Buy
2019-07-15	개시	ROTH Capital	Buy

모두보기

Akero Therapeutics Inc 주식(AKRO)의 최신 뉴스

Apr 20, 2025

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Akero Therapeutics, Inc. (AKRO) and Encourages Investors to Learn More About the Investigation - markets.businessinsider.com

Apr 20, 2025

Walleye Capital LLC Acquires Shares of 134,705 Akero Therapeutics, Inc. (NASDAQ:AKRO) - MarketBeat

Apr 20, 2025

Apr 19, 2025

Akero Therapeutics, Inc. (NASDAQ:AKRO) Shares Sold by Geode Capital Management LLC - MarketBeat

Apr 19, 2025

Apr 18, 2025

University of Wisconsin Foundation Has $11.42 Million Stock Position in Akero Therapeutics, Inc. (NASDAQ:AKRO) - MarketBeat

Apr 18, 2025

Catriona Yale Sells 9,073 Shares of Akero Therapeutics, Inc. (NASDAQ:AKRO) Stock - MarketBeat

Apr 18, 2025

8,336 Shares in Akero Therapeutics, Inc. (NASDAQ:AKRO) Bought by Optimize Financial Inc - MarketBeat

Apr 18, 2025